
An Analysis of ARS Pharmaceuticals Inc (SPRY)’s Potential Price Growth
ARS Pharmaceuticals Inc’s recent filing unveils that its Chief Commercial Officer Karas Eric unloaded Company’s shares for reported $0.25 million
ARS Pharmaceuticals Inc’s recent filing unveils that its Chief Commercial Officer Karas Eric unloaded Company’s shares for reported $0.25 million
ARS Pharmaceuticals Inc’s filing revealed that its 10% Owner Flynn James E unloaded Company’s shares for reported $13.66 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, ARS Pharmaceuticals Inc revealed its Chief Commercial Officer Karas Eric unloaded Company’s shares for reported $0.24 million
ARS Pharmaceuticals Inc’s filing revealed that its Chief Legal Officer Fitzpatrick Alexander A unloaded Company’s shares for reported $1.45 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or